Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

559 ARTÍCULOS , VIENDO DEL 451 AL 465

Plasmalogens inhibit neuroinflammation and promote cognitive function

Hossain MS, Mawatari S, Fujino T.

Brain Res Bull. 2023 Jan;192:56-61. doi: 10.1016/j.brainresbull.2022.11.005. Epub 2022 Nov 5.

Plasma Exchange in Alzheimer's Disease

Rohrer L, Yunce M, Montine TJ, Shan H.

Transfus Med Rev. 2023 Jan;37(1):10-15. doi: 10.1016/j.tmrv.2022.09.005. Epub 2022 Oct 3.

Pathophysiological mechanism and natural preventive and therapeutic strategies of Alzheimer's disease

Basli A, Bounaas J.

Nutr Health. 2023 Sep;29(3):403-413. doi: 10.1177/02601060221137104. Epub 2022 Nov 14.

Ginsenoside Rg1 in neurological diseases: From bench to bedside

Yang SJ, Wang JJ, Cheng P, Chen LX, Hu JM, Zhu GQ.

Acta Pharmacol Sin. 2023 May;44(5):913-930. doi: 10.1038/s41401-022-01022-1. Epub 2022 Nov 15.

The metal ion hypothesis of Alzheimer's disease and the anti-neuroinflammatory effect of metal chelators

Chen LL, Fan YG, Zhao LX, Zhang Q, Wang ZY.

Bioorg Chem. 2023 Feb;131:106301. doi: 10.1016/j.bioorg.2022.106301. Epub 2022 Nov 25.

Postulating the possible cellular signalling mechanisms of antibody drug conjugates in Alzheimer's disease

Punyakoti P, Behl T, Sehgal A, Yadav S, Sachdeva M, Anwer MK, Vargas-De-La-Cruz C, Venkatachalam T, Naqvi M, Verma R, Tuli HS.

Cell Signal. 2023 Feb;102:110539. doi: 10.1016/j.cellsig.2022.110539. Epub 2022 Nov 29.

Beyond the classical amyloid hypothesis in Alzheimer's disease: Molecular insights into current concepts of pathogenesis, therapeutic targets, and study models

Theerasri A, Janpaijit S, Tencomnao T, Prasansuklab A.

WIREs Mech Dis. 2023 Mar;15(2):e1591. doi: 10.1002/wsbm.1591. Epub 2022 Dec 9.

Unmasking BACE1 in aging and age-related diseases

Bao H, Shen Y.

Trends Mol Med. 2023 Feb;29(2):99-111. doi: 10.1016/j.molmed.2022.11.008. Epub 2022 Dec 9.

Role of Tau in Various Tauopathies, Treatment Approaches, and Emerging Role of Nanotechnology in Neurodegenerative Disorders

Kaur P, Khera A, Alajangi HK, Sharma A, Jaiswal PK, Singh G, Barnwal RP.

Mol Neurobiol. 2023 Mar;60(3):1690-1720. doi: 10.1007/s12035-022-03164-z. Epub 2022 Dec 23.

Does Multicomponent Physical Exercise Training Work for Dementia? Exploring the Effects on Cognition, Neuropsychiatric Symptoms, and Quality of Life

Borges-Machado F, Teixeira L, Carvalho J, Ribeiro O.

J Geriatr Psychiatry Neurol. 2023 Sep;36(5):376-385. doi: 10.1177/08919887221149152. Epub 2022 Dec 27.

Role of multi-targeted bioactive natural molecules and their derivatives in the treatment of Alzheimer's disease: an insight into structure-activity relationship

Halder D, Das S, R S J, Joseph A.

J Biomol Struct Dyn. 2023 Dec;41(20):11286-11323. doi: 10.1080/07391102.2022.2158136. Epub 2022 Dec 29.

Role of monomeric amyloid-β in cognitive performance in Alzheimer's disease: Insights from clinical trials with secretase inhibitors and monoclonal antibodies

Imbimbo BP, Ippati S, Watling M, Imbimbo C.

Pharmacol Res. 2023 Jan;187:106631. doi: 10.1016/j.phrs.2022.106631. Epub 2022 Dec 28.

Noradrenergic therapies for apathy in Alzheimer's disease?

Husain M.

J Neurol Neurosurg Psychiatry. 2023 Feb;94(2):93. doi: 10.1136/jnnp-2022-330824. Epub 2022 Dec 5.

Did the COVID-19 Pandemic Affect the Use of Antipsychotics Among Nursing Home Residents With ADRD?

Yan D, Temkin-Greener H, Cai S.

Am J Geriatr Psychiatry. 2023 Feb;31(2):124-140. doi: 10.1016/j.jagp.2022.09.009. Epub 2022 Sep 28.

Chronic pain in Alzheimer's disease: Endocannabinoid system

Blanton H, Reddy PH, Benamar K.

Exp Neurol. 2023 Feb;360:114287. doi: 10.1016/j.expneurol.2022.114287. Epub 2022 Nov 29.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias